Now is the time to recognize how an abundance of material things is taking up space in your home (and your brain). Put on ...

Shares of BioAge (NASDAQ:BIOA) cratered 70% Friday in post-market trading after the company said it was discontinuing a Phase 2 study for its ... Updates stock move.) More on BioAge Labs, Inc.

In this multicentre retrospective study, we collected data for patients with lung cancer who had a biopsy and multigene next-generation sequencing done at 16 hospitals in China (with no restrictions ...

Uranium Royalty's (TSE:URC) stock is up by a considerable 25% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term ...

(RTTNews) - Atea Pharmaceuticals, Inc. (AVIR) Wednesday revealed that its Phase 2 study of Bemnifosbuvir and Ruzasvir Regimen for the treatment of Hepatitis C Virus or HCV achieved primary ...

Phase 2a proof-of-concept study is expected to begin in the first half of 2025. Price Action: RLMD stock is down 75.4% at $0.68 at last check Wednesday.

In December 2023, the MIT Tech Review published an article with the headline “Making an image with generative AI uses as much energy as charging your phone.” Most users of image generation tools, ...

Wall Street has been paying a lot of attention to the stock, thanks to the impressive clinical performance of JANX007. Management had previously provided an update on the above study earlier in ...

His career has included major stints at the Australian Treasury, the OECD, the Asian Development Bank Institute and Tokyo’s Sophia University. Image of Xi Jinping and Vladimir Putin with the President ...